CLINICAL_TRIALS ClinicalTrials.gov record update

A DoubleBlind Phase 2b Study to Evaluate Safety & Efficacy of Different Doses of Tyrosine Adsorbed Birch+Hazel+Alder Pollen Allergoid With MPL® in Patients Sensitized to Birch, Hazel, Alder Pollen

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00118612
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:49.540571+00:00
Published At: 2021-02-09T00:00:00+00:00
Record Updated At: 2021-02-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Type I Hypersensitivity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-09"
protocolSection.identificationModule.nctId: "NCT00118612"
protocolSection.identificationModule.officialTitle: "A DoubleBlind Phase 2b Study to Evaluate Safety \u0026 Efficacy of Different Doses of Tyrosine Adsorbed Birch+Hazel+Alder Pollen Allergoid With MPL\u00ae in Patients Sensitized to Birch, Hazel, Alder Pollen"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.